Trial Profile
Steady State Pharmacokinetics of 80 mg Telmisartan (Micardis), 10 mg Ramipril (Delix) or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers (an Open-label, Randomised, Multiple-dose, Three-way Crossover Study)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Telmisartan (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 25 Aug 2014 New trial record